Back to Newsroom
Back to Newsroom

Creative Edge Nutrition Inc. (FITX) Announces the Appointment of Deloitte as Audit Firm

Thursday, 19 June 2014 09:48 AM

Creative Edge Nutrition, Inc.

Topic:

MADISON HEIGHTS, MI / Accesswire / June 19, 2014 / Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX) is pleased to announce the retention of Deloitte as our audit firm.

"We are extremely pleased and excited to announce the retention of Deloitte as the independent auditing firm to aid us in our transition to a higher exchange.  I have stated the company’s desire to uplist to a higher exchange numerous times. Finding a qualified independent auditor is key to this success. We are making great strides toward this effort" stated Bill Chaaban, President & CEO of Creative Edge Nutrition, Inc.  

About CEN Biotech

CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

http://www.cenbiotechinc.com

About Creative Edge Nutrition, Inc.

Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com and https://www.facebook.com/CenergyNutrition

Contact:

FOR INVESTOR RELATIONS

William Swalm

(212) 584-4342

[email protected]

SOURCE: CEN Biotech

Topic:
Back to newsroom
Back to Newsroom
Share by: